210 related articles for article (PubMed ID: 11067393)
1. The implications of a Medicare prescription drug benefit.
Manag Care Interface; 2000 May; 13(5):44-5. PubMed ID: 11067393
[No Abstract] [Full Text] [Related]
2. The challenge of expanding health benefits for the aged.
Elwood TW
J Allied Health; 2000; 29(4):189-95. PubMed ID: 11147184
[No Abstract] [Full Text] [Related]
3. By the numbers. The rising costs of prescription drugs.
Thornton D
Healthplan; 1999; 40(5):71-2. PubMed ID: 10622972
[No Abstract] [Full Text] [Related]
4. A first look at the new Medicare prescription drug plans.
Frakt AB; Pizer SD
Health Aff (Millwood); 2006; 25(4):W252-61. PubMed ID: 16720588
[TBL] [Abstract][Full Text] [Related]
5. Lessons for Medicare Part D in the hemodialysis community.
Nayeem AI; Chertow GM
BMC Nephrol; 2006 Jul; 7():11. PubMed ID: 16824211
[TBL] [Abstract][Full Text] [Related]
6. The Medicare Prescription Drug, Improvement, and Modernization Act of 2003.
Emmer S; Allendorf L
J Am Geriatr Soc; 2004 Jun; 52(6):1013-5. PubMed ID: 15161471
[No Abstract] [Full Text] [Related]
7. The prescription-drug problem.
Steinbrook R
N Engl J Med; 2002 Mar; 346(11):790. PubMed ID: 11893789
[No Abstract] [Full Text] [Related]
8. Medicare prescription drug benefit variations.
Manag Care Interface; 1999 Oct; 12(10):36. PubMed ID: 10623003
[No Abstract] [Full Text] [Related]
9. Advocating for a Medicare prescription drug benefit.
Rother J
Yale J Health Policy Law Ethics; 2003; 3(2):279-90. PubMed ID: 14577144
[No Abstract] [Full Text] [Related]
10. What will the new medicare drug benefit mean for Minnesota physicians?
Liebow M
Minn Med; 2005 Mar; 88(3):38-41. PubMed ID: 15852596
[TBL] [Abstract][Full Text] [Related]
11. The impact of Medicare Part D on prescription drug use by the elderly.
Lichtenberg FR; Sun SX
Health Aff (Millwood); 2007; 26(6):1735-44. PubMed ID: 17978393
[TBL] [Abstract][Full Text] [Related]
12. The Medicare prescription drug plan: assisting our older patients.
Klein MN
ORL Head Neck Nurs; 2004; 22(4):34-5. PubMed ID: 15617318
[TBL] [Abstract][Full Text] [Related]
13. Medicare prescription drugs and reform: what the new law will mean to gastroenterologists and their patients.
Fise T
Am J Gastroenterol; 2004 May; 99(5):775-6. PubMed ID: 15128335
[No Abstract] [Full Text] [Related]
14. Medicare drugs.
Poisal JA
Health Care Financ Rev; 2003; 25(2):1-5. PubMed ID: 15124373
[TBL] [Abstract][Full Text] [Related]
15. Status report on Medicare Part D enrollment in 2006: analysis of plan-specific market share and coverage.
Cubanski J; Neuman P
Health Aff (Millwood); 2007; 26(1):w1-12. PubMed ID: 17118944
[TBL] [Abstract][Full Text] [Related]
16. Medicare and the politics of prescription drug pricing.
Oberlander J
N C Med J; 2003; 64(6):303-4. PubMed ID: 14983626
[No Abstract] [Full Text] [Related]
17. Affordable prescription drugs--state and federal action.
Ohio Nurses Rev; 2003 Aug; 78(7):4. PubMed ID: 15134064
[No Abstract] [Full Text] [Related]
18. Prescription drug costs for Medicare beneficiaries: coverage and health status matter.
Stuart B; Shea D; Briesacher B
Issue Brief (Commonw Fund); 2000 Jan; (365):1-9. PubMed ID: 11584831
[No Abstract] [Full Text] [Related]
19. Prescription drugs in Medicare and the ESRD program.
Powe NR
Semin Nephrol; 2000 Nov; 20(6):535-42. PubMed ID: 11111855
[TBL] [Abstract][Full Text] [Related]
20. Prescription drug pricing: the consumer perspective.
Searing A
N C Med J; 2003; 64(6):300-2. PubMed ID: 14983625
[No Abstract] [Full Text] [Related]
[Next] [New Search]